Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1087

2.

Recent advances in the treatment of rheumatoid arthritis.

Mahajan TD, Mikuls TR.

Curr Opin Rheumatol. 2018 Feb 15. doi: 10.1097/BOR.0000000000000496. [Epub ahead of print]

PMID:
29461286
3.

Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial.

Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S, Kakroodi FA, Bolurieh T, Hosseini SE, Chehrazi M, Niknejadi M, Baharvand H, Gharibdoost F, Aghdami N.

Cytotherapy. 2018 Feb 7. pii: S1465-3249(18)30001-X. doi: 10.1016/j.jcyt.2017.12.009. [Epub ahead of print]

PMID:
29428486
6.

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis.

Vena GA, Cassano N, Iannone F.

Ther Clin Risk Manag. 2018 Jan 9;14:105-116. doi: 10.2147/TCRM.S154745. eCollection 2018. Review.

7.

Treatment of chronic chikungunya arthritis with methotrexate: a systematic review.

Amaral JK, Sutaria R, Schoen RT.

Arthritis Care Res (Hoboken). 2018 Jan 23. doi: 10.1002/acr.23519. [Epub ahead of print]

PMID:
29361202
8.

Mavrilimumab, a fully human granulocyte-macrophage colony-stimulating factor receptor α monoclonal antibody: long-term safety and efficacy in patients with rheumatoid arthritis.

Burmester GR, McInnes IB, Kremer JM, Miranda P, Vencovský J, Godwood A, Albulescu M, Michaels MA, Guo X, Close D, Weinblatt M.

Arthritis Rheumatol. 2018 Jan 23. doi: 10.1002/art.40420. [Epub ahead of print]

PMID:
29361199
9.

Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.

van Vollenhoven RF, Keystone EC, Strand V, Pacheco-Tena C, Vencovský J, Behrens F, Racewicz A, Zipp D, Rharbaoui F, Wolter R, Knierim L, Schmeidl R, Zhou X, Aigner S, Dälken B, Wartenberg-Demand A; TREAT2b study team.

Ann Rheum Dis. 2018 Jan 17. pii: annrheumdis-2017-212478. doi: 10.1136/annrheumdis-2017-212478. [Epub ahead of print]

PMID:
29343509
10.

Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis.

Baek HJ, Lim MJ, Park W, Park SH, Shim SC, Yoo DH, Kim HA, Lee SK, Lee YJ, Park YE, Cha HS, Song YW.

Korean J Intern Med. 2018 Jan 17. doi: 10.3904/kjim.2017.159. [Epub ahead of print]

11.

Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world setting.

Alten R, Burkhardt H, Feist E, Krüger K, Rech J, Rubbert-Roth A, Voll RE, Elbez Y, Rauch C.

Arthritis Res Ther. 2018 Jan 2;20(1):1. doi: 10.1186/s13075-017-1488-5.

12.

Tumor Necrosis Factor (TNF) Inhibitors for Rheumatic Diseases (Part 2): A Systematic Review of Data From Registries and Safety Databases [Internet].

Arentz-Hansen H, Palm Ø, Natvig Norderhaug I, Klemp Gjertsen M, Nordvåg BY.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2007 Feb.

13.

Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.

Naniwa T, Iwagaitsu S, Kajiura M.

Int J Rheum Dis. 2018 Jan 4. doi: 10.1111/1756-185X.13248. [Epub ahead of print]

PMID:
29314738
14.

Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis.

Kang YM, Park YE, Park W, Choe JY, Cho CS, Shim SC, Bae SC, Suh CH, Cha HS, Koh EM, Song YW, Yoo B, Lee SS, Park MC, Lee SH, Arendt C, Koetse W, Lee SK.

Korean J Intern Med. 2018 Jan 5. doi: 10.3904/kjim.2016.213. [Epub ahead of print]

15.
16.

Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.

Hakamata J, Hashiguchi M, Kaneko Y, Yamaoka K, Shimizu M, Maruyama J, Takeuchi T, Mochizuki M.

Mod Rheumatol. 2018 Jan 2:1-10. doi: 10.1080/14397595.2017.1414765. [Epub ahead of print]

PMID:
29252093
17.

Liquid chromatographic methods for the therapeutic drug monitoring of methotrexate as clinical decision support for personalized medicine: A brief review.

Silva MF, Ribeiro C, Gonçalves VMF, Tiritan ME, Lima Á.

Biomed Chromatogr. 2017 Dec 11. doi: 10.1002/bmc.4159. [Epub ahead of print] Review.

PMID:
29226354
18.

Radiolabeled methotrexate as a diagnostic agent of inflammatory target sites: A proof-of-concept study.

Papachristou M, Kastis GA, Stavrou PZ, Xanthopoulos S, Furenlid LR, Datseris IE, Bouziotis P.

Mol Med Rep. 2018 Feb;17(2):2442-2448. doi: 10.3892/mmr.2017.8166. Epub 2017 Nov 27.

19.

Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.

Edwards CJ, J K Östör A, Naisbett-Groet B, Kiely P.

Rheumatology (Oxford). 2018 Jan 1;57(1):84-91. doi: 10.1093/rheumatology/kex358.

PMID:
29155973
20.

Supplemental Content

Loading ...
Support Center